On the morning of September 26, 2026, Russian forces launched another targeted strike on the territory of the well-known Ukrainian pharmaceutical enterprise Darnytsia, located in Kyiv. According to preliminary official data from the company's press service, there were no fatalities or injuries among the plant's employees as a result of this hostile attack. The incident has caused widespread resonance in society, given the strategic importance of the facility for ensuring uninterrupted supplies of medicines to the Ukrainian market.
Systematic Attacks on the Capital's Pharmaceutical Infrastructure
This incident is not an isolated case of aggression against the Ukrainian pharmaceutical industry. As company management reminds, the previous strike on the Darnytsia plant was recorded quite recently—on September 23, 2026. In addition, a major hostile attack on the same enterprise took place in June of this year. The systematic shelling of civilian production facilities of critical infrastructure indicates deliberate pressure on the economy and life-support logistics of the Ukrainian capital.
Calls for Information Silence and Security Measures
Immediately after the morning shelling, representatives of the pharmaceutical company appealed to citizens, media, and bloggers with a persuasive request to observe strict information silence. The company's management strongly recommends not publishing photo and video materials from the scene, refraining from detailed descriptions of the strike's consequences, and not leaving clarifying comments in social networks. Such measures are necessary to avoid providing the adversary with additional data for fire adjustment and evaluating the effectiveness of attacks.
Risks for the Pharmaceutical Market and Situation Assessment
Despite regular strikes on production facilities, the management of Darnytsia previously assured specialized publications, including RBC-Ukraine, that the enterprise is taking all necessary measures to minimize the risks of medicine shortages. Experts are also monitoring the pricing policy in the medicine market, although the exact scale of material damage from today's attack is still being clarified by specialized services and expert commissions.
